At the J.P. Morgan Healthcare Conference, digital health was highlighted for lacking a clear definition. Many attendees said the various qualities and approaches to digital health tools can cause confusion. For more JPM coverage, take a look at MM&M’s recaps from the first and second day of the conference. (CNBC)
Former Celgene executive is joining Bluebird Bio as SVP for its Europe operation. She is replacing Andrew Obenshain and will be based in Zug, Switzerland. (Endpoints)
GoodRx cofounder has created a website that provides patients with cancer survival rates. Stephen Buck said the site is meant to make information about prognoses easier to access for patients so they can begin thinking about their future. All information in the tool is based on data from the National Cancer Institute. (STAT)
UnitedHealth Group’s revenue increased by 7% in Q4 of 2019. The health insurer cited high enrollment in Medicare Advantage, adding hundreds of thousands of seniors. Its Optum health services businesses, including pharmacy benefit manager OptumRx, also contributed to the growth. (Forbes)
We’ve extended the nomination deadline for our 2020 classes of MM&M Hall of Femme and Women to Watch. Nominate an inspirational woman in healthcare by January 22. (MM&M)
